Journal
Neuro-Oncology Advances
Publication Date
1-1-2020
Volume
2
Issue
1
First Page
vdaa126
Document Type
Open Access Publication
DOI
10.1093/noajnl/vdaa126
Rights and Permissions
Sirui Ma, Soumon Rudra, Jian L Campian, Sonika Dahiya, Gavin P Dunn, Tanner Johanns, Michael Goldstein, Albert H Kim, Jiayi Huang, Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma, Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa126, https://doi.org/10.1093/noajnl/vdaa126. © The Author(s) 2020. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Ma, Sirui; Rudra, Soumon; Campian, Jian L; Dahiya, Sonika; Dunn, Gavin P; Johanns, Tanner; Goldstein, Michael; Kim, Albert H; and Huang, Jiayi, "Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma." Neuro-Oncology Advances. 2, 1. vdaa126 (2020).
https://digitalcommons.wustl.edu/oa_4/756
Additional Links
Supplemental material is available for this article at publisher site.
